Equities

Pliant Therapeutics Inc

Pliant Therapeutics Inc

Actions
  • Price (EUR)13.00
  • Today's Change0.20 / 1.56%
  • Shares traded0.00
  • 1 Year change+9.24%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments494331201
Total Receivables, Net3.002.072.08
Total Inventory------
Prepaid expenses6.996.896.76
Other current assets, total1.270.17--
Total current assets506340209
Property, plant & equipment, net4.789.9111
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.390.390.84
Total assets512351221
LIABILITIES
Accounts payable4.531.582.97
Accrued expenses242214
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total------
Total current liabilities292417
Total long term debt109.930
Total debt109.930
Deferred income tax------
Minority interest------
Other liabilities, total03.435.33
Total liabilities393722
SHAREHOLDERS EQUITY
Common stock0.010.010.00
Additional paid-in capital973654414
Retained earnings (accumulated deficit)(500)(338)(215)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.35(1.96)(0.2)
Total equity474313199
Total liabilities & shareholders' equity512351221
Total common shares outstanding604936
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.